These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 12271721)

  • 1. [The comparative characteristics of the safety, immunogenic activity and prophylactic potency of the adult and children types of live influenza vaccine in schoolchildren aged 7-14 years].
    Grigor'eva EP; Desheva IuA; Donina SA; Naĭkhin AN; Rekstin AR; Barantseva IB; Zavitkova EA; Moskvicheva TM; Zhavoronkov VG; Rudenko LG
    Vopr Virusol; 2002; 47(4):24-7. PubMed ID: 12271721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The investigation of the safety, genetic stability and immunogenicity of live influenza vaccine for adults in vaccination of 3-6 years old children].
    Desheva IuA; Danini GV; Grigor'eva EP; Donina SA; Kiseleva IV; Rekstin AR; Ermakova LA; Natsina VK; Nikolaeva VM; Lonskaia NI; El'shina GA; Zhavoronkov VG; Drinevskiĭ VP; Erofeeva MK; Naĭkhin AN; Rudenko LG
    Vopr Virusol; 2002; 47(4):21-4. PubMed ID: 12271720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Advantages and disadvantages of inactivated and live influenza vaccine].
    Gendon IuZ
    Vopr Virusol; 2004; 49(4):4-12. PubMed ID: 15293504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Increase in the effectiveness of anti-influenza immunization by use of a combination of inactivated and live vaccine].
    Smorodintsev AA; Orlov VA; Ermolaeva OM; Zhilova GP
    Vopr Virusol; 1978; (5):602-7. PubMed ID: 735019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Assessment of the prophylactic effectiveness of an inactivated influenza vaccine by immunizing schoolchildren in the springtime].
    Vasil'eva RI; Liamtseva GA; Riazantseva TG; Oleĭnikova EV; Sosunov AV
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Mar; (3):10-4. PubMed ID: 2939666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of a 3-year survey of persons inoculated with inactivated inflenza vaccine (IIV). II. The immunological effectiveness of IIV and its comparison with the epidemiological].
    Mukhina LP; Kozlova NA; Rykushin IuP; Bichurina MA; Polzik TP
    Tr Inst Im Pastera; 1979; 52():71-5. PubMed ID: 162089
    [No Abstract]   [Full Text] [Related]  

  • 7. Repeated immunization of children with inactivated and live attenuated influenza virus vaccines: safety, immunogenicity, and protective efficacy.
    Keitel WA
    Semin Pediatr Infect Dis; 2002 Apr; 13(2):112-9. PubMed ID: 12122949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Results of studying the effectiveness of a live influenza vaccine for peroral use on preschool and schoolchildren].
    Slepushkin AN; Dukova VS; Kalegaeva VA; Kagan AN; Temriuk EE
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Dec; (12):24-9. PubMed ID: 4281595
    [No Abstract]   [Full Text] [Related]  

  • 9. Intranasal live attenuated seasonal influenza vaccine: does not challenge current practice.
    Prescrire Int; 2013 Sep; 22(141):201-4. PubMed ID: 24171209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum and mucosal immunologic responses in children following the administration of a new inactivated intranasal anti-influenza vaccine.
    Greenbaum E; Furst A; Kiderman A; Stewart B; Levy R; Schlesinger M; Morag A; Zakay-Rones Z
    J Med Virol; 2001 Sep; 65(1):178-84. PubMed ID: 11505461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Results of a study of a live intranasal influenza vaccine in the immunization of children 3 to 15 years old].
    Rudenko LG; Grigor'eva EP; Drinevskiĭ VP; Koval' TA; Doroshenko EM
    Zh Mikrobiol Epidemiol Immunobiol; 1988 May; (5):41-6. PubMed ID: 2970743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of live attenuated influenza vaccine in mild to moderately immunocompromised children with cancer.
    Halasa N; Englund JA; Nachman S; Weinberg GA; Huber VC; Allison K; Dubovsky F; Yi T; McCullers JA; Flynn PM
    Vaccine; 2011 May; 29(24):4110-5. PubMed ID: 21496468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The use of saliva for study in the immunoenzyme analysis of postvaccinal and postinfectious immunity to influenza].
    Naĭkhin AN; Mikhaĭlov AA; Kustikova IuG; Tsybalova LM; Klimovich VB; Artem'eva SA; Krasheniuk AI; Katorgina LG; Kim TN; Denisov GM
    Vopr Virusol; 1993; 38(5):201-4. PubMed ID: 8284915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Secretory and serum response after intranasal influenza vaccination with A/Victoria attenuated live virus].
    Crifò S; Filiaci F; Pelosio A; Rocchi G
    Boll Soc Ital Biol Sper; 1978 Jun; 54(11):1021-6. PubMed ID: 743410
    [No Abstract]   [Full Text] [Related]  

  • 15. [Interrelationships between serum and secretory antibodies in immunization with live influenza vaccine].
    Shvartsman IaS; Krylov VA; Agranovskaia EN; Mal'tseva AI
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Aug; (8):35-8. PubMed ID: 128269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Safety and high immunogenicity for children 3 to 15 of a mono- and a divaccine from recombinant influenza A/Brazil /11/78 (H1N1) and A/Bangkok/1/79 (H3N2) viruses obtained from a special donor attenuation base--the cold-adapted virus A/Leningrad/134/47/57 (H2N2)].
    Polezhaev FI; Budilovskiĭ GN; Garmashova LM; Romeĭko-Gurko IuR; Egorov AIu
    Vopr Virusol; 1983; 28(6):710-4. PubMed ID: 6670253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and immunogenicity in man of a cell culture derived trivalent live attenuated seasonal influenza vaccine: a Phase I dose escalating study in healthy volunteers.
    Heldens J; Hulskotte E; Voeten T; Breedveld B; Verweij P; van Duijnhoven W; Rudenko L; van Damme P; van den Bosch H
    Vaccine; 2014 Sep; 32(39):5118-24. PubMed ID: 24858566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Importance of secretory antibodies in nonsusceptibility to influenza B disease and the prevention of the spread of this virus].
    Tsybul'skaia NV; Popova TL; Ispolatova AV; Tsybalova LM; Oleĭnikova EV
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Jul; (7):81-3. PubMed ID: 6226166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
    Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?
    Tamura S; Ainai A; Suzuki T; Kurata T; Hasegawa H
    Jpn J Infect Dis; 2016; 69(3):165-79. PubMed ID: 27212584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.